Articles on this page are updated by ProfileData Research on an hourly basis. To see the summary of the SENS notice, please click on the headline. To read the original SENS message, please click on the link in the summary.



Date Headline/Title
07 December 2016Report on Annual General Meeting proceedings
04 November 2016No Change Statement and Notice of Annual General Meeting 6 December 2016
03 November 2016Dealing in Aspen Securities by the company secretary of Aspen
02 November 2016Dealing in securities by directors and the company secretary
14 October 2016Share dealings in securities by directors associates
13 October 2016Dealing in securities by directors and company secretary
13 October 2016Dealing in Aspen securities
05 October 2016Notification in terms of section 122(3) of the Companies Act and section 3.83(b) of the JSE listings requirements
05 October 2016Notification in terms of Section 122(3) of the Companies Act and Section 3.83(b) of the JSE Listings Requirements
29 September 2016GSK announces sale of its remaining stake in Aspen
14 September 2016Aspen final results 30 June 2016
12 September 2016Results for the year ended 30 June 2016 and Results Presentation
12 September 2016Voluntary announcement - Aspen announces signing of agreements with GSK
07 September 2016Trading Statement
01 September 2016Further announcement regarding a commercialisation agreement with Astrazeneca in anaesthetics
16 August 2016Results of General Meeting Proceedings
12 August 2016Appointment of Maureen Manyama to the Aspen Social & Ethics Committee
15 July 2016Notice of General Meeting - 15 August 2016
09 June 2016Commercialisation agreement signing
08 June 2016Aspen closes EUR 3 000 000 000 equivalent facilities arrangements
26 May 2016Dealings in Aspen securities by the Aspen Share Incentive Trust
17 May 2016Aspen agreement with ANI Pharmaceuticals
31 March 2016Appointment of an Independent Non-executive Director: Babalwa Ngonyama
03 March 2016Aspen interim results 31 December 2015
01 March 2016Results for the half-year ended 31 December 2015 and interim results presentation
23 February 2016Trading Statement
19 February 2016Launch of HPC in the United States
19 January 2016Aspen Pharmacare Holdings Limited announces change of Transfer Secretary
Powered by ProfileData